Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway.

The human beta(2)-adrenergic receptor (betaAR) is rapidly desensitized in response to saturating concentrations of agonist by G protein-coupled receptor kinases (GRKs) and cAMP-dependent protein kinase A (PKA) phosphorylation of the betaAR, followed by beta-arrestin binding and receptor internalization. betaAR sites phosphorylated by GRK in vivo have not yet been identified. In this study, we examined the role of the carboxyl terminal serines, 355, 356, and 364, in the GRK-mediated desensitization of the betaAR. Substitution mutants of these serine residues were constructed in which either all three (S355,356,364A), two (S355,356A and S356, 364A), or one of the serines (S356A and S364A) were modified. These mutants were constructed in a betaAR in which the serines of the PKA consensus site were substituted with alanines (designated PKA(-)) to eliminate any PKA contribution to desensitization, and they were stably transfected into human embryonic kidney 293 cells. Treatment of the PKA(-) mutant with 10 microM epinephrine for 5 min caused a 3. 5-fold increase in the EC(50) value and a 42% decrease in the V(max) value for epinephrine stimulation of adenylyl cyclase. Substitution of all three serines completely inhibited the epinephrine-induced shift in the EC(50). Both double mutants, S355,356A and S356,364A, showed a nearly complete loss of the EC(50) shift, whereas the single substitutions, S356A and S364A, caused only a slight decrease in desensitization. None of the mutations altered the epinephrine-induced decrease in V(max,) which seems to be downstream of the receptor. The triple mutation caused a 45% decrease in epinephrine-induced internalization and a 90 to 95% reduction in phosphorylation of the betaAR relative to the PKA(-) (1.9+/- 0.2- and 16.6+/-3.8-fold phosphorylation over basal, respectively). The double mutants caused an intermediate reduction in internalization (20-21%) and phosphorylation (43-52%). None of the serine mutations altered the rate of betaAR recycling. Our data demonstrate that the cluster of serines within the 355 to 364 betaAR domain confer the rapid, GRK-mediated, receptor-level desensitization of the betaAR.

[1]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.

[2]  G. Brooker,et al.  (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells. , 1980, Journal of cyclic nucleotide research.

[3]  J. Friedman,et al.  Epinephrine desensitization of adenylate cyclase from cyc- and S49 cultured lymphoma cells. , 1981, Journal of cyclic nucleotide research.

[4]  R. Clark,et al.  Adenylate cyclase coupling proteins are not essential for agonist-specific desensitization of lymphoma cells. , 1981, The Journal of biological chemistry.

[5]  P. Molinoff,et al.  Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists. , 1984, Molecular pharmacology.

[6]  S. W. Hall,et al.  Light‐induced binding of 48‐kDa protein to photoreceptor membranes is highly enhanced by phosphorylation of rhodopsin , 1984, FEBS letters.

[7]  S. W. Hall,et al.  Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Caron,et al.  Light-dependent phosphorylation of rhodopsin by beta-adrenergic receptor kinase. , 1986, Nature.

[9]  M. Caron,et al.  Light-dependent phosphorylation of rhodopsin by β-adrenergic receptor kinase , 1986, Nature.

[10]  M. Caron,et al.  Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitization , 1988, Nature.

[11]  M. Kunkel,et al.  Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  N. Bennett,et al.  Inactivation of photoexcited rhodopsin in retinal rods: the roles of rhodopsin kinase and 48-kDa protein (arrestin). , 1988, Biochemistry.

[13]  M. Caron,et al.  Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. , 1989, The Journal of biological chemistry.

[14]  C. Strader,et al.  Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase. , 1989, Molecular pharmacology.

[15]  S. Shenolikar,et al.  Cell‐free heterologous desensitization of adenylyl cyclase in S49 lymphoma cell membranes mediated by cAMP‐dependent protein kinase , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  M. Caron,et al.  beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.

[17]  J. Benovic.  Purification and characterization of beta-adrenergic receptor kinase. , 1987, Methods in enzymology.

[18]  M. Caron,et al.  Structure and regulation of G protein-coupled receptors: the beta 2-adrenergic receptor as a model. , 1991, Vitamins and hormones.

[19]  M. Caron,et al.  A small region of the beta-adrenergic receptor is selectively involved in its rapid regulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Palczewski,et al.  G-protein-coupled receptor kinases. , 1991, Trends in biochemical sciences.

[21]  J L Benovic,et al.  Visual arrestin interaction with rhodopsin. Sequential multisite binding ensures strict selectivity toward light-activated phosphorylated rhodopsin. , 1993, The Journal of biological chemistry.

[22]  R. Lefkowitz,et al.  Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. , 1993, The Journal of biological chemistry.

[23]  L. Birnbaumer,et al.  Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. , 1994, Molecular pharmacology.

[24]  J. Edwardson,et al.  Kinetic analysis of the trafficking of muscarinic acetylcholine receptors between the plasma membrane and intracellular compartments. , 1994, The Journal of biological chemistry.

[25]  H. Hamm,et al.  Arrestin-rhodopsin interaction. Multi-site binding delineated by peptide inhibition. , 1994, The Journal of biological chemistry.

[26]  R. Clark,et al.  cAMP-dependent protein kinase and protein kinase C consensus site mutations of the beta-adrenergic receptor. Effect on desensitization and stimulation of adenylylcyclase. , 1994, The Journal of biological chemistry.

[27]  M. Caron,et al.  Role of phosphorylation in agonist-promoted beta 2-adrenergic receptor sequestration. Rescue of a sequestration-defective mutant receptor by beta ARK1. , 1995, The Journal of biological chemistry.

[28]  A. Milam,et al.  Rhodopsin Phosphorylation and Dephosphorylation in Vivo(*) , 1995, The Journal of Biological Chemistry.

[29]  M. Caron,et al.  Role of Phosphorylation in Agonist-promoted β2-Adrenergic Receptor Sequestration , 1995, The Journal of Biological Chemistry.

[30]  津賀 浩史.  Sequestration of muscarinic acetylcholine receptor m2 subtypes : facilitation by G protein-coupled receptor kinase (GRK2) and attenuation by a dominant-negative mutant of GRK2 , 1995 .

[31]  R Barber,et al.  Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution. , 1996, Molecular pharmacology.

[32]  J. Benovic,et al.  Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. , 1996, Nature.

[33]  R. Lefkowitz,et al.  Identification of the G Protein-coupled Receptor Kinase Phosphorylation Sites in the Human β2-Adrenergic Receptor* , 1996, The Journal of Biological Chemistry.

[34]  M. Caron,et al.  Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization , 1996, Science.

[35]  M. Caron,et al.  Dynamin and β-Arrestin Reveal Distinct Mechanisms for G Protein-coupled Receptor Internalization* , 1996, The Journal of Biological Chemistry.

[36]  J. Benovic,et al.  β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor , 1996, Nature.

[37]  M. Caron,et al.  Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization. , 1997, Molecular pharmacology.

[38]  A. Seibold,et al.  β2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists* , 1997, The Journal of Biological Chemistry.

[39]  R. Pals-Rylaarsdam,et al.  Two Homologous Phosphorylation Domains Differentially Contribute to Desensitization and Internalization of the m2 Muscarinic Acetylcholine Receptor* , 1997, The Journal of Biological Chemistry.

[40]  G. Büldt,et al.  X-ray crystal structure of arrestin from bovine rod outer segments , 1998, Nature.

[41]  B. J. Knoll,et al.  Salmeterol‐induced desensitization, internalization and phosphorylation of the human β2‐adrenoceptor , 1998, British journal of pharmacology.

[42]  J. Friedman,et al.  Desensitization of β2-Adrenergic Receptors with Mutations of the Proposed G Protein-coupled Receptor Kinase Phosphorylation Sites* , 1998, The Journal of Biological Chemistry.

[43]  J. Benovic,et al.  Arrestin-independent Internalization of the m1, m3, and m4 Subtypes of Muscarinic Cholinergic Receptors* , 1998, The Journal of Biological Chemistry.

[44]  J. Benovic,et al.  The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.

[45]  J. Benovic,et al.  Visualization of Agonist-induced Sequestration and Down-regulation of a Green Fluorescent Protein-tagged β2-Adrenergic Receptor* , 1998, The Journal of Biological Chemistry.

[46]  V. Gurevich.  The Selectivity of Visual Arrestin for Light-activated Phosphorhodopsin Is Controlled by Multiple Nonredundant Mechanisms* , 1998, The Journal of Biological Chemistry.

[47]  S. Shenolikar,et al.  The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange , 1998, Nature.

[48]  R. Lefkowitz,et al.  Mechanisms of beta-adrenergic receptor desensitization and resensitization. , 1998, Advances in pharmacology.

[49]  A. Bretscher,et al.  A kinase-regulated PDZ-domain interaction controls endocytic sorting of the β2-adrenergic receptor , 1999, Nature.

[50]  P. Sigler,et al.  The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. , 1999, Cell.

[51]  P. Sigler,et al.  A Model for Arrestin’s Regulation: The 2.8 Å Crystal Structure of Visual Arrestin , 1999, Cell.

[52]  C. Chavkin,et al.  Targeted Construction of Phosphorylation-independent β-Arrestin Mutants with Constitutive Activity in Cells* , 1999, The Journal of Biological Chemistry.

[53]  B. J. Knoll,et al.  Partial agonists and G protein-coupled receptor desensitization. , 1999, Trends in pharmacological sciences.

[54]  P B Sigler,et al.  How Does Arrestin Respond to the Phosphorylated State of Rhodopsin?* , 1999, The Journal of Biological Chemistry.

[55]  M. Caron,et al.  Properties of Secretin Receptor Internalization Differ from Those of the β2-Adrenergic Receptor* , 1999, The Journal of Biological Chemistry.